The Department of Medical Biochemistry and Biophysics (MBB) performs basic research and higher education. The aim with our research is to understand fundamental cellular processes and their role in disease.
Researchers from MBB and SciLifeLab receive over 1 million USD in funding. The team is coordinated by Ernest Arenas.
In a recent study published in Cell Chemical Biology, researchers from the Oscar Fernandez-Capetillo group have identified drugs that limit the toxicity of peptides causing the neurodegenerative illness ALS. This might provide new clues to potential therapies.
Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at other areas than just the immune system. The results are published in Nature Medicine.
A new European network studying molecular mechanisms causing vascular anomalies just got funded 3.7 million Euros from the EU Marie Skłodowska-Curie Actions Innovative training networks programme.